Terms of Use
Effective July 17, 2026
Informational website
FL2ai.com provides general information about healthcare-AI opportunity areas, founder readiness, validation, and potential collaboration. The site does not guarantee admission, selection, funding, investment, a pilot, a partnership, commercial results, or any particular outcome.
No professional advice or offer
Site content is not medical, legal, investment, tax, or other professional advice. It is not an offer to sell or a solicitation of an offer to buy securities or other financial products. Obtain advice from qualified professionals before making regulated, clinical, legal, or financial decisions.
Acceptable use
You agree not to:
- Submit false, unlawful, infringing, malicious, or misleading information
- Submit protected health information, credentials, patient records, or other sensitive data
- Attempt to bypass access controls, rate limits, spam filters, or other security measures
- Interfere with the site, probe it for unauthorized purposes, or introduce harmful code
- Copy or present site content in a way that falsely implies endorsement, affiliation, or authorship
Content and third-party links
Unless otherwise stated, site text, layout, and original materials are provided for personal and internal business evaluation. Third-party names, links, and materials remain the property of their respective owners. A link does not by itself establish endorsement, sponsorship, or control of the linked service.
Availability and disclaimers
The site is provided on an “as available” basis. We may change, suspend, correct, or remove content and features. To the extent permitted by law, the site operators disclaim implied warranties and are not liable for indirect, incidental, special, consequential, or punitive damages arising from use of the site.
Privacy, changes, and contact
Use of the contact form is also governed by the Privacy Policy. We may update these terms, with the effective date identifying the current version. Questions may be sent to admin@goodsam.ai.